Merck | MRK - Cost Of Sales


Merck reported EUR2.07B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Adidas EUR 3.22B 235M Mar/2026
Adyen EUR 226.65M 10M Dec/2025
Akzo Nobel EUR 1.41B 28M Mar/2026
Alcon AG USD 1.18B 26M Mar/2026
Amadeus IT EUR 589.5M 51.6M Mar/2026
Amarin USD 26.05M 1.41M Dec/2025
AstraZeneca USD -204M 3.48B Mar/2026
BASF EUR 11.87B 941M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Danone EUR 6.73B 17M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Genmab DKK 81M 23M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Henkel EUR 4.96B 110M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Infineon EUR 2.34B 136M Mar/2026
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Linde USD 5.5B 1.12B Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
UCB EUR 1.07B 146M Dec/2025